ArticleComputational and structural biotechnology journal2026
Minimum-Cost Synthetic Genome Planning: An Algorithmic Framework.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As synthetic genomics scales toward the construction of increasingly larger genomes, computational strategies are needed to address technical feasibility. We introduce an algorithmic framework for the minimum-cost synthetic genome planning problem, aiming to identify the most cost-effective strategy to assemble a target genome from a source genome through a combination of reuse, synthesis, and join operations. By comparing dynamic programming and greedy heuristic strategies under diverse cost regimes, we demonstrate how algorithmic choices influence the cost efficiency of large-scale genome construction. In parallel, solving the minimum-cost synthetic genome planning problem can help us better understand genome architecture and evolution. Using both single closely related templates (e.g., bat coronavirus RaTG13) and diverse multisource consensus analyses, our results revealed that conserved regions such as ORF1ab can be reconstructed cost-effectively via sequence reuse. In contrast, highly variable regions such as the S (Spike) gene necessitate expensive
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.